Avenu Medical

About Avenu Medical

Avenu Medical, now part of Medtronic, specializes in developing innovative vascular access solutions for hemodialysis patients. Founded in 2010 and headquartered in Orange County, California, the company has created the Ellipsys Vascular Access System, a minimally invasive, image-guided, single catheter system designed to percutaneously create an arteriovenous (AV) fistula. This system addresses the unmet clinical needs in the vascular access market by providing a cost-effective and efficient alternative to traditional surgical methods, which have remained unchanged for over 50 years.

Avenu Medical's primary clients include hospitals, outpatient departments, ambulatory surgery centers, and office-based labs, particularly those specializing in interventional radiology, vascular surgery, nephrology, and cardiology. The company's business model focuses on selling its patented Ellipsys system to these medical facilities, generating revenue through product sales and potentially through service agreements for ongoing support and training.

The market for Avenu Medical's products is expanding due to the increasing prevalence of end-stage renal disease (ESRD), driven by rising rates of diabetes, hypertension, and obesity. The aging population and higher life expectancy of dialysis patients further contribute to the growing demand for effective hemodialysis access solutions. With a track record of over 2000 successful procedures and long-term functional patency, Avenu Medical is well-positioned to capitalize on this growing market.